Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
| Role | Insider | Date | Transaction | Value | Shares |
|---|---|---|---|---|---|
| CEO | Lee-Sepsick Kathy | Aug 7, 2026 | Buy | $50K | 15,625 |
| Chief Technology Officer | Sipos Jeremy Alexander | Aug 7, 2026 | Buy | $10K | 3,125 |
| CFO | Elefant Dov | Aug 7, 2026 | Buy | $50K | 15,625 |
| Chief Clinical-Medical Affairs | Mifek Jeffrey Gerald | Aug 7, 2026 | Buy | $10K | 3,125 |
| Chief Operating Officer | Canning John Charles | Aug 7, 2026 | Buy | $14K | 4,375 |
| Director | Dyett John | Jun 23, 2021 | Buy | $9.95K | 1,000 |
| Director | Adams John Q JR | Jun 22, 2021 | Buy | $520K | 40,000 |
| Director | Larsen Charles | Jun 22, 2021 | Buy | $91K | 7,000 |
| Director | Uzialko Edward R | Jun 22, 2021 | Buy | $1.3M | 100,000 |
| Director | Dyett John | Jun 22, 2021 | Buy | $520K | 40,000 |
| Director | Dyett John | Jun 18, 2021 | Buy | $32.95K | 2,500 |
| Director | Dyett John | Jun 18, 2021 | Buy | $128.8K | 10,000 |
Open-market purchases and sales reported on SEC form 4 over the last 10years. Awards, option exercises, gifts and other non-market form 4 activity are excluded. Chart markers group a day's filings by direction; the table lists each filing.